Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lockshin, MD
   Genome and hormones: Gender differences in physiology - Invited review: Sex ratio and rheumatic disease
   JOURNAL OF APPLIED PHYSIOLOGY
   
   M.D. Lockshin, "Genome and hormones: Gender differences in physiology - Invited review: Sex ratio and rheumatic disease", J APP PHYSL, 91(5), 2001, pp. 2366-2373
2. Qasim, A; Seery, J; O'Morain, CA
   5-Aminosalicylates in inflammatory bowel disease: choosing the right dose
   DIGESTIVE AND LIVER DISEASE
   
   A. Qasim et al., "5-Aminosalicylates in inflammatory bowel disease: choosing the right dose", DIG LIVER D, 33(5), 2001, pp. 393-398
3. Uomo, G; Talamini, G; Rabitti, PG
   Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients
   DIGESTIVE AND LIVER DISEASE
   
   G. Uomo et al., "Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients", DIG LIVER D, 33(1), 2001, pp. 58-62
4. Freund, YR; Dousman, L; Riccio, ES; Sato, B; MacGregor, JT; Mohagheghpour, N
   Immunohematotoxicity studies with combinations of dapsone and zidovudine
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   Y.R. Freund et al., "Immunohematotoxicity studies with combinations of dapsone and zidovudine", INT IMMUNO, 1(12), 2001, pp. 2131-2141
5. Bruserud, O
   Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   O. Bruserud, "Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia", INT IMMUNO, 1(12), 2001, pp. 2183-2195
6. Amichai, B; Grunwald, MH; Brenner, L
   Fexofenadine hydrochloride - A new anti-histaminic drug
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   B. Amichai et al., "Fexofenadine hydrochloride - A new anti-histaminic drug", ISR MED ASS, 3(3), 2001, pp. 207
7. Adachi, JD
   Corticosteroid-induced osteoporosis
   INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
   
   J.D. Adachi, "Corticosteroid-induced osteoporosis", INT J F W M, 46(4), 2001, pp. 190-205
8. Spanknebel, K; Conlon, KCP
   Advances in the surgical management of pancreatic cancer
   CANCER JOURNAL
   
   K. Spanknebel e K.C.P. Conlon, "Advances in the surgical management of pancreatic cancer", CANCER J, 7(4), 2001, pp. 312-323
9. Godder, KT; Henslee-Downey, PJ
   Colony-stimulating factors in stem cell transplantation: Effect on qualityof life
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   K.T. Godder e P.J. Henslee-Downey, "Colony-stimulating factors in stem cell transplantation: Effect on qualityof life", J HEMATH ST, 10(2), 2001, pp. 215-228
10. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
    Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    B. Masquelier et al., "Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA", J ACQ IMM D, 28(4), 2001, pp. 309-312
11. Deeks, SG; Barditch-Crovo, P; Collier, A; Smith, A; Miller, M; McGowan, M; Coakley, DF
    Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S.G. Deeks et al., "Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate", J ACQ IMM D, 28(4), 2001, pp. 336-339
12. Loveday, C
    Nucleoside reverse transcriptase inhibitor resistance
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Loveday, "Nucleoside reverse transcriptase inhibitor resistance", J ACQ IMM D, 26, 2001, pp. S10-S24
13. Lee, KA; Zaffke, ME; Baratte-Beebe, K
    Restless legs syndrome and sleep disturbance during pregnancy: The role offolate and iron
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    
    K.A. Lee et al., "Restless legs syndrome and sleep disturbance during pregnancy: The role offolate and iron", J WOMEN H G, 10(4), 2001, pp. 335-341
14. Visted, T; Bjerkvig, R; Enger, PO
    Cell encapsulation technology as a therapeutic strategy for CNS malignancies
    NEURO-ONCOLOGY
    
    T. Visted et al., "Cell encapsulation technology as a therapeutic strategy for CNS malignancies", NEURO-ONCOL, 3(3), 2001, pp. 201-210
15. Doherty, M; Dougados, M
    Evidence-based management of osteoarthritis: practical issues relating to the data
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M. Doherty e M. Dougados, "Evidence-based management of osteoarthritis: practical issues relating to the data", BEST PR R C, 15(4), 2001, pp. 517-525
16. Hochberg, MC; Dougados, M
    Pharmacological therapy of osteoarthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M.C. Hochberg e M. Dougados, "Pharmacological therapy of osteoarthritis", BEST PR R C, 15(4), 2001, pp. 583-593
17. O'Dell, JR
    How is it best to treat early rheumatoid arthritis patients?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    J.R. O'Dell, "How is it best to treat early rheumatoid arthritis patients?", BEST PR R C, 15(1), 2001, pp. 125-137
18. Hofmeyr, GJ
    Hypovolaemic shock
    BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    
    G.J. Hofmeyr, "Hypovolaemic shock", BEST P R CL, 15(4), 2001, pp. 645-662
19. Estey, EH
    Growth factors in acute myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    E.H. Estey, "Growth factors in acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 175-187
20. Bidaut-Russell, M; Gabriel, SE
    Adverse gastrointestinal effects of NSAIDs: consequences and costs
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M. Bidaut-Russell e S.E. Gabriel, "Adverse gastrointestinal effects of NSAIDs: consequences and costs", BEST PR RES, 15(5), 2001, pp. 739-753
21. McCarthy, DM
    Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    D.M. McCarthy, "Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs", BEST PR RES, 15(5), 2001, pp. 755-773
22. van Leerdam, ME; Rauws, EAJ
    The role of acid suppressants in upper gastrointestinal ulcer bleeding
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M.E. van Leerdam e E.A.J. Rauws, "The role of acid suppressants in upper gastrointestinal ulcer bleeding", BEST PR RES, 15(3), 2001, pp. 463-475
23. Simopoulos, AP
    Evolutionary aspects of diet, essential fatty acids and cardiovascular disease
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    A.P. Simopoulos, "Evolutionary aspects of diet, essential fatty acids and cardiovascular disease", EUR H J SUP, 3(D), 2001, pp. D8-D21
24. Singh, RB; Niaz, MA; Kartik, C
    Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis?
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    R.B. Singh et al., "Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis?", EUR H J SUP, 3(D), 2001, pp. D62-D69
25. Marchioli, R
    Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    R. Marchioli, "Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial", EUR H J SUP, 3(D), 2001, pp. D85-D97
26. Famularo, G; Di Marzio, L; Ulisse, S; Cifone, MG; De Simone, C
    Alternative strategies other than growth hormone for the treatment of immune diseases
    TRENDS IN IMMUNOLOGY
    
    G. Famularo et al., "Alternative strategies other than growth hormone for the treatment of immune diseases", TRENDS IMMU, 22(1), 2001, pp. 14-15
27. Masihi, KN
    Fighting infection using immunomodulatory agents
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    K.N. Masihi, "Fighting infection using immunomodulatory agents", EXPERT OP B, 1(4), 2001, pp. 641-653
28. Cleveland, DW; Rothstein, JD
    From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
    NATURE REVIEWS NEUROSCIENCE
    
    D.W. Cleveland e J.D. Rothstein, "From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS", NAT REV NEU, 2(11), 2001, pp. 806-819
29. Steiner, M; Romano, SJ; Babcock, S; Dillon, J; Shuler, C; Berger, C; Carter, D; Reid, R; Stewart, D; Steinberg, S; Judge, R
    The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    M. Steiner et al., "The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder", BR J OBST G, 108(5), 2001, pp. 462-468
30. Adekanmi, OA; Purmessur, S; Edwards, G; Barrington, JW
    Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    O.A. Adekanmi et al., "Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage", BR J OBST G, 108(5), 2001, pp. 541-542
31. Chong, YS; Chua, S; El-Refaey, H; Choo, WL; Chanrackakul, B; Tai, BC; Rodeck, C; Arulkumaran, S
    Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    Y.S. Chong et al., "Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine", BR J OBST G, 108(1), 2001, pp. 41-47
32. Mitsumoto, H
    Clinical trials: present and future
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    H. Mitsumoto, "Clinical trials: present and future", AMYOTROPH L, 2, 2001, pp. S10-S14
33. Meininger, V
    Clinical trials: the past, a lesson for the future
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    V. Meininger, "Clinical trials: the past, a lesson for the future", AMYOTROPH L, 2, 2001, pp. S15-S18
34. Kirby, RS; Andersen, M; Gratzke, P; Dahlstrand, C; Hoye, K
    A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia
    BJU INTERNATIONAL
    
    R.S. Kirby et al., "A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia", BJU INT, 87(3), 2001, pp. 192-200
35. Gerloni, V; Cimaz, R; Gattinara, M; Arnoldi, C; Pontikaki, I; Fantini, F
    Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study
    RHEUMATOLOGY
    
    V. Gerloni et al., "Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study", RHEUMATOLOG, 40(8), 2001, pp. 907-913
36. Lawson, TM; Amos, N; Bulgen, D; Williams, BD
    Minocycline-induced lupus: clinical features and response to rechallenge
    RHEUMATOLOGY
    
    T.M. Lawson et al., "Minocycline-induced lupus: clinical features and response to rechallenge", RHEUMATOLOG, 40(3), 2001, pp. 329-335
37. Khan, A; Khan, SR; Leventhal, RM; Brown, WA
    Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    
    A. Khan et al., "Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database", IN J NEUROP, 4(2), 2001, pp. 113-118
38. Skinner, SA; Polglase, AL; Le, CT; Winnett, JD
    Treatment of anal fissure with glyceryl trinitrate in patients referred for surgical management
    ANZ journal of surgery
    
    S.A. Skinner et al., "Treatment of anal fissure with glyceryl trinitrate in patients referred for surgical management", AUST NZ J S, 71(4), 2001, pp. 218-220
39. Stehouwer, CDA
    Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: Insights from studies of vascular structure and function
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    C.D.A. Stehouwer, "Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: Insights from studies of vascular structure and function", CLIN CH L M, 39(8), 2001, pp. 705-709
40. Apfel, SC
    Neurotrophic factor therapy - Prospects and problems
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    S.C. Apfel, "Neurotrophic factor therapy - Prospects and problems", CLIN CH L M, 39(4), 2001, pp. 351-355
41. Hansel, TT; Barnes, PJ
    Clinical studies on new drugs
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    T.T. Hansel e P.J. Barnes, "Clinical studies on new drugs", PROG R RES, 31, 2001, pp. 48-51
42. Brane, G; Gottfries, CG; Winblad, B
    The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    G. Brane et al., "The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials", DEMENT G C, 12(1), 2001, pp. 1-14
43. Hansen, KS; Vieths, S; Vestergaard, N; Skov, PS; Bindslev-Jensen, C; Poulsen, LK
    Seasonal variation in food allergy to apple
    JOURNAL OF CHROMATOGRAPHY B
    
    K.S. Hansen et al., "Seasonal variation in food allergy to apple", J CHROMAT B, 756(1-2), 2001, pp. 19-32
44. Poulsen, LK
    In vivo and in vitro techniques to determine the biological activity of food allergens
    JOURNAL OF CHROMATOGRAPHY B
    
    L.K. Poulsen, "In vivo and in vitro techniques to determine the biological activity of food allergens", J CHROMAT B, 756(1-2), 2001, pp. 41-55
45. Hansen, KS; Bindslev-Jensen, C; Skov, PS; Sparholt, SH; Hansen, GN; Niemeijer, NR; Malling, HJ; Poulsen, LK
    Standardization of food allergen extracts for skin prick test
    JOURNAL OF CHROMATOGRAPHY B
    
    K.S. Hansen et al., "Standardization of food allergen extracts for skin prick test", J CHROMAT B, 756(1-2), 2001, pp. 57-69
46. Lanas, A; Santolaria, S
    Gastroesophageal reflux disease (GERD): Current agents and future perspective
    CURRENT PHARMACEUTICAL DESIGN
    
    A. Lanas e S. Santolaria, "Gastroesophageal reflux disease (GERD): Current agents and future perspective", CUR PHARM D, 7(1), 2001, pp. 1-18
47. Wilkinson, D
    Drugs for treatment of Alzheimer's disease
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    D. Wilkinson, "Drugs for treatment of Alzheimer's disease", INT J CL PR, 55(2), 2001, pp. 129-134
48. Small, G
    Meeting the challenges of vascular dementia - Introduction
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. Small, "Meeting the challenges of vascular dementia - Introduction", INT J CL PR, 2001, pp. 1-4
49. Maelicke, A
    The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    A. Maelicke, "The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))", INT J CL PR, 2001, pp. 24-28
50. Gauthier, S; Ferris, S
    Outcome measures for probable vascular dementia and Alzheimers disease with cerebrovascular disease
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    S. Gauthier e S. Ferris, "Outcome measures for probable vascular dementia and Alzheimers disease with cerebrovascular disease", INT J CL PR, 2001, pp. 29-39
51. Squires, KE
    An introduction to nucleoside and nucleotide analogues
    ANTIVIRAL THERAPY
    
    K.E. Squires, "An introduction to nucleoside and nucleotide analogues", ANTIVIR TH, 6, 2001, pp. 1-14
52. McGill, JB
    Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone
    BLOOD PRESSURE MONITORING
    
    J.B. McGill, "Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone", BL PRESS M, 6, 2001, pp. S3-S13
53. Lacourciere, Y
    Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone
    BLOOD PRESSURE MONITORING
    
    Y. Lacourciere, "Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone", BL PRESS M, 6, 2001, pp. S23-S30
54. O'Brien, J; Robinson, L; Fairbairn, A
    Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication
    PRIMARY CARE PSYCHIATRY
    
    J. O'Brien et al., "Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication", PRIM CARE P, 7(3), 2001, pp. 111-113
55. Pandit, SA; Argyropoulos, S; Nutt, DJ
    Current status of anxiolytic drugs
    PRIMARY CARE PSYCHIATRY
    
    S.A. Pandit et al., "Current status of anxiolytic drugs", PRIM CARE P, 7(1), 2001, pp. 1-5
56. Pedersen, A
    Topical treatment of recurrent herpes labialis
    ORAL DISEASES
    
    A. Pedersen, "Topical treatment of recurrent herpes labialis", ORAL DIS, 7(1), 2001, pp. 1-1
57. Femiano, F; Gombos, F; Scully, C
    Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir)
    ORAL DISEASES
    
    F. Femiano et al., "Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir)", ORAL DIS, 7(1), 2001, pp. 31-33
58. Reusser, P
    Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    P. Reusser, "Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts", EXPERT OP I, 10(9), 2001, pp. 1745-1753
59. Carrol, ED; Thomson, APJ; Hart, CA
    New therapies and vaccines for meningococcal disease
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    E.D. Carrol et al., "New therapies and vaccines for meningococcal disease", EXPERT OP I, 10(8), 2001, pp. 1487-1500
60. Rodrigues, CMP; Steer, CJ
    The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    C.M.P. Rodrigues e C.J. Steer, "The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent", EXPERT OP I, 10(7), 2001, pp. 1243-1253
61. Herrick, AL
    Development of agents for the treatment of systemic sclerosis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    A.L. Herrick, "Development of agents for the treatment of systemic sclerosis", EXPERT OP I, 10(7), 2001, pp. 1255-1264
62. Bowden, CL
    Novel treatments for bipolar disorder
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    C.L. Bowden, "Novel treatments for bipolar disorder", EXPERT OP I, 10(4), 2001, pp. 661-671
63. Theoharides, TC; Sant, GR
    New agents for the medical treatment of interstitial cystitis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    T.C. Theoharides e G.R. Sant, "New agents for the medical treatment of interstitial cystitis", EXPERT OP I, 10(3), 2001, pp. 521-546
64. Diener, HC; Limmroth, V
    Advances in pharmacological treatment of migraine
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    H.C. Diener e V. Limmroth, "Advances in pharmacological treatment of migraine", EXPERT OP I, 10(10), 2001, pp. 1831-1845
65. Mastrandrea, F
    Immunotherapy in atopic dermatitis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    F. Mastrandrea, "Immunotherapy in atopic dermatitis", EXPERT OP I, 10(1), 2001, pp. 49-63
66. Guttman, M; Jaskolka, J
    The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?
    PARKINSONISM & RELATED DISORDERS
    
    M. Guttman e J. Jaskolka, "The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?", PARKINS R D, 7(3), 2001, pp. 231-234
67. Wolinksy, JS; Narayana, PA; Johnson, KP
    United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates
    MULTIPLE SCLEROSIS
    
    J.S. Wolinksy et al., "United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates", MULT SCLER, 7(1), 2001, pp. 33-41
68. Barnes, MP; Gilhus, NE; Wender, M
    Task force on minimum standards for health care of people with multiple sclerosis: June 1999
    EUROPEAN JOURNAL OF NEUROLOGY
    
    M.P. Barnes et al., "Task force on minimum standards for health care of people with multiple sclerosis: June 1999", EUR J NEUR, 8(3), 2001, pp. 215-220
69. Marta, A; Vittorio, DP; Lenzi, GL
    The fight against stroke: victories, defeats, strategies
    CURRENT OPINION IN NEUROLOGY
    
    A. Marta et al., "The fight against stroke: victories, defeats, strategies", CURR OP NEU, 14(1), 2001, pp. 55-57
70. Mouthon, L; Agard, C
    Treating systemic sclerosis in 2001
    JOINT BONE SPINE
    
    L. Mouthon e C. Agard, "Treating systemic sclerosis in 2001", JOINT BONE, 68(5), 2001, pp. 393-402
71. Steidler, L
    Microbiological and immunological strategies for treatment of inflammatorybowel disease
    MICROBES AND INFECTION
    
    L. Steidler, "Microbiological and immunological strategies for treatment of inflammatorybowel disease", MICROBES IN, 3(13), 2001, pp. 1157-1166
72. Ryan, ET; Calderwood, SB
    Cholera vaccines
    JOURNAL OF TRAVEL MEDICINE
    
    E.T. Ryan e S.B. Calderwood, "Cholera vaccines", J TRAVEL M, 8(2), 2001, pp. 82-91
73. Greenwood, CE; Young, SN
    Dietary fat intake and the brain: a developing frontier in biological psychiatry
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    C.E. Greenwood e S.N. Young, "Dietary fat intake and the brain: a developing frontier in biological psychiatry", J PSYCH NEU, 26(3), 2001, pp. 182-184
74. Lynch, ME
    Antidepressants as analgesics: a review of randomized controlled trials
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    M.E. Lynch, "Antidepressants as analgesics: a review of randomized controlled trials", J PSYCH NEU, 26(1), 2001, pp. 30-36
75. Passalacqua, G; Canonica, GW
    Allergen-specific sublingual immunotherapy for respiratory allergy
    BIODRUGS
    
    G. Passalacqua e G.W. Canonica, "Allergen-specific sublingual immunotherapy for respiratory allergy", BIODRUGS, 15(8), 2001, pp. 509-519
76. Krishnagopalan, S; Dellinger, RP
    Innovative therapies for sepsis
    BIODRUGS
    
    S. Krishnagopalan e R.P. Dellinger, "Innovative therapies for sepsis", BIODRUGS, 15(10), 2001, pp. 645-654
77. Clanet, M
    Interferon-beta in the treatment of multiple sclerosis - Do clinical data support the existence of a ceiling effect?
    CLINICAL DRUG INVESTIGATION
    
    M. Clanet, "Interferon-beta in the treatment of multiple sclerosis - Do clinical data support the existence of a ceiling effect?", CLIN DRUG I, 21(4), 2001, pp. 307-318
78. Russell, JM; Mackell, JA
    Bodyweight gain associated with atypical antipsychotics - Epidemiology andtherapeutic implications
    CNS DRUGS
    
    J.M. Russell e J.A. Mackell, "Bodyweight gain associated with atypical antipsychotics - Epidemiology andtherapeutic implications", CNS DRUGS, 15(7), 2001, pp. 537-551
79. Hankey, GJ; Eikelboom, JW
    Homocysteine levels in patients with stroke - Clinical relevance and therapeutic implications
    CNS DRUGS
    
    G.J. Hankey e J.W. Eikelboom, "Homocysteine levels in patients with stroke - Clinical relevance and therapeutic implications", CNS DRUGS, 15(6), 2001, pp. 437-443
80. Imbimbo, BP
    Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease
    CNS DRUGS
    
    B.P. Imbimbo, "Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease", CNS DRUGS, 15(5), 2001, pp. 375-390
81. Parry, BL
    The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder - Therapeutic implications
    CNS DRUGS
    
    B.L. Parry, "The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder - Therapeutic implications", CNS DRUGS, 15(4), 2001, pp. 277-285
82. Rubenstein, LM; DeLeo, A; Chrischilles, EA
    Economic and health-related quality of life considerations of new therapies in Parkinson's disease
    PHARMACOECONOMICS
    
    L.M. Rubenstein et al., "Economic and health-related quality of life considerations of new therapies in Parkinson's disease", PHARMACOECO, 19(7), 2001, pp. 729-752
83. Rahme, E; Joseph, L; Kong, SX; Watson, DJ; Pellissier, JM; LeLorier, J
    Gastrointestinal-related healthcare resource usage associated with a fixedcombination of diclofenac and misoprostol versus other NSAIDs
    PHARMACOECONOMICS
    
    E. Rahme et al., "Gastrointestinal-related healthcare resource usage associated with a fixedcombination of diclofenac and misoprostol versus other NSAIDs", PHARMACOECO, 19(5), 2001, pp. 577-588
84. Burke, TA; Zabinski, RA; Pettitt, D; Maniadakis, N; Maurath, CJ; Goldstein, JL
    A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis
    PHARMACOECONOMICS
    
    T.A. Burke et al., "A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis", PHARMACOECO, 19(1), 2001, pp. 33-47
85. Zabinski, RA; Burke, TA; Johnson, J; Lavoie, F; Fitzsimon, C; Tretiak, R; Chancellor, JVM
    An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada
    PHARMACOECONOMICS
    
    R.A. Zabinski et al., "An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada", PHARMACOECO, 19(1), 2001, pp. 49-58
86. Chancellor, JVM; Hunsche, E; de Cruz, E; Sarasin, FP
    Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland
    PHARMACOECONOMICS
    
    J.V.M. Chancellor et al., "Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland", PHARMACOECO, 19(1), 2001, pp. 59-75
87. Hemels, MEH; Lanctot, KL; Iskedjian, M; Einarson, TR
    Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia
    DRUGS & AGING
    
    M.E.H. Hemels et al., "Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia", DRUG AGING, 18(7), 2001, pp. 527-550
88. Hesse, S; Brandl-Hesse, B; Bardeleben, A; Werner, C; Funk, M
    Botulinum toxin A treatment of adult upper and lower limb spasticity
    DRUGS & AGING
    
    S. Hesse et al., "Botulinum toxin A treatment of adult upper and lower limb spasticity", DRUG AGING, 18(4), 2001, pp. 255-262
89. Jensen, PG; Larson, JR
    Management of painful diabetic neuropathy
    DRUGS & AGING
    
    P.G. Jensen e J.R. Larson, "Management of painful diabetic neuropathy", DRUG AGING, 18(10), 2001, pp. 737-749
90. Byerly, MJ; Weber, MT; Brooks, DL; Snow, LR; Worley, MA; Lescouflair, E
    Antipsychotic medications and the elderly - Effects on cognition and implications for use
    DRUGS & AGING
    
    M.J. Byerly et al., "Antipsychotic medications and the elderly - Effects on cognition and implications for use", DRUG AGING, 18(1), 2001, pp. 45-61
91. Mones, J; Guilera, M; Artes, M; Lopez, JS; Guerrero, T; Fillat, O
    Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    J. Mones et al., "Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia", REV ESP E D, 93(5), 2001, pp. 287-292
92. Periti, P; Tonelli, F
    Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii
    JOURNAL OF CHEMOTHERAPY
    
    P. Periti e F. Tonelli, "Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii", J CHEMOTHER, 13(5), 2001, pp. 473-493
93. Edelstein, MA; Martin, P
    Chronic hepatitis C: Current status and rationale for antiviral therapy
    EUROPEAN JOURNAL OF SURGERY
    
    M.A. Edelstein e P. Martin, "Chronic hepatitis C: Current status and rationale for antiviral therapy", EURO J SURG, 167, 2001, pp. 49-55
94. Raviele, A; Giada, F; Sutton, R; Alboni, P; Brignole, M; Del Rosso, A; Di Girolamo, E; Luise, R; Menozzi, C
    The Vasovagal Syncope and Pacing (Synpace) trial: rationale and study design
    EUROPACE
    
    A. Raviele et al., "The Vasovagal Syncope and Pacing (Synpace) trial: rationale and study design", EUROPACE, 3(4), 2001, pp. 336-341
95. Sheldon, R; Rose, S
    Components of clinical trials for vasovagal syncope
    EUROPACE
    
    R. Sheldon e S. Rose, "Components of clinical trials for vasovagal syncope", EUROPACE, 3(3), 2001, pp. 233-240
96. Carroll, PV; Van den Berghe, G
    Safety aspects of pharmacological GH therapy in adults
    GROWTH HORMONE & IGF RESEARCH
    
    P.V. Carroll e G. Van den Berghe, "Safety aspects of pharmacological GH therapy in adults", GROWTH H I, 11(3), 2001, pp. 166-172
97. Tisdale, MJ
    Loss of skeletal muscle in cancer: Biochemical mechanisms
    FRONTIERS IN BIOSCIENCE
    
    M.J. Tisdale, "Loss of skeletal muscle in cancer: Biochemical mechanisms", FRONT BIOSC, 6, 2001, pp. D164-D174
98. Winokur, A; Gary, KA; Rodner, S; Rae-Red, C; Fernando, AT; Szuba, MR
    Depression, sleep physiology, and antidepressant drugs
    DEPRESSION AND ANXIETY
    
    A. Winokur et al., "Depression, sleep physiology, and antidepressant drugs", DEPRESS ANX, 14(1), 2001, pp. 19-28
99. Dunner, DL
    Management of anxiety disorders: The added challenge of comorbidity
    DEPRESSION AND ANXIETY
    
    D.L. Dunner, "Management of anxiety disorders: The added challenge of comorbidity", DEPRESS ANX, 13(2), 2001, pp. 57-71
100. La Vaque, TJ; Rossiter, TR
     A comment on La Vague and Rossiter - Response
     APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK
     
     T.J. La Vaque e T.R. Rossiter, "A comment on La Vague and Rossiter - Response", APPL PSY BI, 26(1), 2001, pp. 67-71